PhRMA, EC unhappy with Indian patent examination draft

Save

The Pharmaceutical Research and Manufacturers of America (PhRMA) in its comments on the draft guidelines has raised concern over a clutch of provisions including the "additional limitations" incorporated into Section 3d by implying that "enhancement of…